Description
Larotrectinib (LOXO-101) is an orally administered inhibitor of the TRK kinase, demonstrating high selectivity exclusively for the TRK family of receptors (IC50s = 2-20 nM).
Molecular Formula
C21H22F2N6O2
Smiles
O[C@H]1CCN(C1)C(=O)NC1CNN2CCC(NC12)N1CCC[C@@H]1C1CC(F)CCC1F
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 4.6 mg/mL (10.74 mM)
Relative Density
1.55 (Predicted)